MARSHALL WACE, LLP

Position in RLAY — Relay Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in RLAY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$333,842

-$9,037,315 QoQ

Shares Held

17,843

-98.1% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#171

of 256 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. RLAY ranks #229 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$333,842	17,843	-98.1%	Shares	Other	2026-08-13
2026-03-31	$9,371,157	941,825	+1721.8%	Shares	Other	2026-05-15
2025-06-30	$178,874	51,698	+86.2%	Shares	Other	2025-08-13
2024-12-31	$114,403	27,768	-98.0%	Shares	Other	2025-02-13
2024-09-30	$9,952,454	1,405,714	+408.0%	Shares	Other	2024-11-14
2024-06-30	$1,804,097	276,702	+10972.5%	Shares	Other	2024-08-14
2021-12-31	$76,744	2,499	-87.3%	Shares	Other	2022-02-14
2021-09-30	$622,086	19,730	-77.8%	Shares	Sole	2021-11-15
2021-06-30	$3,250,326	88,831	+779.3%	Shares	Sole	2021-08-13
2021-03-31	$349,226	10,102	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.